Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0000899243-20-030431

Chairman sold 40,000 shares at an average $90.59 ($3,623,600)

  • Chairman acquired 40,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

El-Hibri Fuad · Chairman

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-02 Exercise or conversion : show line 1 in the form +20,000 $26.45 $529,000 1,143,988 D
2020-11-02 Sale : show line 2 in the form −20,000 $90.44 $1,808,800 1,123,988 D
2020-11-03 Exercise or conversion : show line 3 in the form +20,000 $26.45 $529,000 1,143,988 D
2020-11-03 Sale : show line 4 in the form −20,000 $90.74 $1,814,800 1,123,988 D
Open-market sales · 40,000 sh · avg $90.59 · $3,623,600

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-11-02 Exercise or conversion : show line 5 in the form Stock Options (Right to Buy) −20,000 59,391 D
2020-11-03 Exercise or conversion : show line 6 in the form Stock Options (Right to Buy) −20,000 39,391 D
Loading xslF345X03/doc4.xml…